Article Information
History
- September 2, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Carolyn T. Bramante, MD, MPH1,*,#,
- Christopher J. Tignanelli, MD2,*,
- Nirjhar Dutta, DO, MS1,
- Emma Jones, MD2,
- Leonardo Tamaritz, MD3,
- Jeanne Clark, MD, MPH4,
- Genevieve Melton-Meaux, MD, PhD2,
- Michael Usher, MD, PhD1 and
- Sayeed Ikramuddin, MD.2
- 1Department of Medicine, University of Minnesota, Division of General Internal Medicine, Minneapolis, MN
- 2Department of Surgery, University of Minnesota Division of Surgical Oncology, Minneapolis, MN
- 3University of Miami, Division of Cardiology and Miami VA Healthcare administration, Miami, FL
- 4Department of Medicine, Johns Hopkins School of Medicine, Division of General Internal Medicine
- ↵#Correspondence: Carolyn T. Bramante MD, MPH, 420 Delaware St SE, MMC 276, Minneapolis, MN 55455, Office: (651) 717-8915, Fax: (612) 626-0439, Email: bramante{at}umn.edu
↵* Authors contributed equally
Posted September 02, 2020.
Non-alcoholic fatty liver disease (NAFLD) and risk of hospitalization for Covid-19
